ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices
ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment.
ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment.
Device42 Discovery & Inventory insights enables you to solve problems faster and manage IT more efficiently
UK market rose to all-time high of £12.4bn last year, with NHS paying for nearly £3.5bn of procedures to ease backlog
When Chelsea Smith met Jason Martin she knew right away that he was the one — so she refused to get his phone number. That’s…
Objective This paper provides an in-depth examination of public attitudes towards salt reduction across seven culturally diverse countries: the USA, the UK, France, Japan, Indonesia,…
Two weeks ago, I wrote about how difficult it is for R&D leaders to “pick winners,” despite the enormous incentives to do so. I explained…
The latest philanthropic trend, no matter how well intended, might be making health-care inequality worse.
UCLA scientists have identified the protein GPNMB as a critical regulator in the heart’s healing process after a heart attack.
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular…
Peter Thiel, the contrarian investor, had a favorite question for interviewees: “What important truth do few people agree with you on?” My answer: No one…